The financial regulator’s inquiry into Mr Guinane’s actions during the tracker mortgage scandal will begin at 10:30 am on February 21 and is expected to last until Mid-March.
GSK has made a major push into long-acting HIV drugs as it works to soften the blow from the loss of exclusivity of its blockbuster drug dolutegravir, which is set to face competition in the US in 2028 and in Europe by 2029.